Literature DB >> 6116333

Characterization of cells involved in the formation of granuloma. An ultrastructural study on macrophages, epitheloid cells, and giant cells in experimental tubulo-interstitial nephritis.

K H Langer, W Thoenes.   

Abstract

In experimental tubulo-interstitial (anti-basement membrane) nephritis of the rat, granulomatous inflammation develops around immunologically altered tubular basement membranes. The present light- and electron microscopic studies indicate that in the course of the granulomatous reaction, tissue monocytes evolve from blood monocytes and pursue two independent pathways of differentation. On the one hand they may differentiate into macrophages ("distant from tubules") or, alternatively, into epitheloid cells ("adjacent to tubules"). The latter, through cell fusion, develop into multinucleated giant cells of the Langhans' type. The cytoplasmic components of the epitheloid cells and the multinucleated giant cells should be interpreted as an activation of cellular biosynthesis. Its products, upon being secreted at the immunodefective basement membrane, will obviously serve immune defense mechanisms.

Entities:  

Mesh:

Year:  1981        PMID: 6116333     DOI: 10.1007/bf02912065

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  3 in total

1.  Tubulointerstitial inflammation, cast formation, and renal parenchymal damage in experimental pyelonephritis.

Authors:  B Iványi; J Ormos; J Lantos
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

Review 2.  Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and in man.

Authors:  J R Brentjens; B Noble; G A Andres
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes.

Authors:  Robert R Mercer; Ann F Hubbs; James F Scabilloni; Liying Wang; Lori A Battelli; Sherri Friend; Vincent Castranova; Dale W Porter
Journal:  Part Fibre Toxicol       Date:  2011-07-22       Impact factor: 9.400

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.